SnagRx vs Hers: Compounded Pricing vs FDA Approved Options
SnagRx vs Hers is primarily a tradeoff between low-cost compounded GLP-1s with a locked-in annual rate and higher-cost FDA-approved brand medications with a personalized care team. Early verdict: choose SnagRx if you want bottom-of-market compounded pricing and a flat rate through titration; choose Hers if you prefer FDA-approved, brand-name Wegovy with ongoing dose check-ins.
See SnagRx semaglutide pricing from $69/mo
How these providers differ: pricing, product type, care model, and guarantees
This comparison focuses on the most distinctive supported differences: pricing structure and required commitment, whether medications are compounded or FDA-approved, level of ongoing clinical support, shipping and pharmacy sourcing, and outcome or refund guarantees. All statements below use only the supplied facts.
1. Pricing and commitment
SnagRx: Compounded semaglutide from $69/month on the 12-month plan and $99/month month-to-month. Compounded tirzepatide from $119/month on the 12-month plan and $149 month-to-month. The $69 and $119 figures are the 12-month plan rates; month-to-month is higher. SnagRx states the 12-month plan saves $360 a year and locks the rate flat at every dose for the life of treatment.
Lock SnagRx pricing for a 12-month plan
Hers: Lists Wegovy starting from $149/month and other brand options from higher price points. Hers requires an active Hers Weight Loss Membership to receive medication; membership details include a first month $39 fee then auto-renew at $149/month thereafter. Hers states medication price includes medication only, if prescribed, and total cost includes membership fees billed separately. Medication is not available without an active membership.
2. Compounded versus FDA-approved medications
SnagRx provides compounded semaglutide and tirzepatide only. The source repeatedly notes these are compounded medications and explicitly states compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. SnagRx names its four US 503A partner pharmacies and its clinician network OpenLoop Health.
View Hers FDA-approved Wegovy options
Hers offers FDA-approved Wegovy brand-name semaglutide and states it provides no compounded products. Hers highlights that Wegovy and Zepbound are FDA-approved for weight loss and that Ozempic is FDA-approved for type 2 diabetes but may be prescribed off-label for weight loss at a clinician’s discretion. Hers emphasizes name brand medication, not compounded alternatives.
3. Clinical support and ongoing monitoring
SnagRx includes a telehealth intake and clinician review delivered by OpenLoop Health clinicians. SnagRx states clinician review typically within five hours and always within 24; prescriptions are filled after clinician review and a declined prescription is refunded in full. SnagRx does not offer coaching or nutrition programming according to the supplied facts.
Hers promotes a personalized care team with ongoing dose check-ins and highlights ongoing monitoring as part of its service. Hers frames its model around a care team and dose check-ins rather than a price-locked compound offering.
4. Shipping, pharmacies, and guarantees
SnagRx states next-day UPS or FedEx shipping in temperature-controlled packaging and names US 503A compounding pharmacies as partners. SnagRx also mentions a full refund if a prescription is declined and a 6-month weight-loss guarantee with terms applied. The company states claims reference self-reported customer data and encourages prospective users to speak with providers about compounded medication risks.
Hers notes medication availability varies and is not available in all 50 states. Hers does not offer compounded medications and points to FDA-approved products. The supplied facts do not list Hers shipping timelines or refund guarantees captured in the evidence.
| Criteria | SnagRx | Hers |
|---|---|---|
| Starting price (semaglutide) | $69/mo on 12-month plan; $99/mo month-to-month | From $149/mo for Wegovy |
| Product type | Compounded semaglutide and tirzepatide only | FDA-approved brand-name Wegovy and other name brands, no compounded meds |
| Commitment required | 12-month plan required for lowest price; month-to-month available | Active membership required for medication; membership billed separately |
| Clinical model | Telehealth with OpenLoop Health clinician review, no coaching | Personalized care team with ongoing dose check-ins |
| Pharmacy and shipping | Named US 503A pharmacies; next-day UPS/FedEx shipping | Not specified in captured evidence; availability varies by state |
Regulatory and safety notes
Both sources state that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Hers offers FDA-approved Wegovy as a non-compounded option. SnagRx states compounded drugs are produced in FDA-regulated facilities but are not finished FDA-approved products and encourages discussion with a clinician about risks.
Conclusion: which to choose in the SnagRx vs Hers decision
SnagRx is best for cost-driven patients who want predictable, bottom-of-market compounded pricing and a price lock through titration on a 12-month plan, with named US 503A pharmacies and next-day shipping. Hers is best for people who prefer FDA-approved, brand-name Wegovy and a personalized care team with ongoing dose check-ins even though starting costs are higher and medication requires an active membership.
Explore Hers membership and Wegovy pricing
Compare SnagRx compounded options and guarantees
Choose SnagRx if you want compounded semaglutide from $69/month on a 12-month plan with price locked at every dose, named US 503A pharmacies, and next-day shipping. Choose Hers if you want FDA-approved Wegovy with a personalized care team and ongoing dose check-ins and are prepared for membership requirements and higher starting prices.